Xylem Weighted Average Exercise Price of Vested and Expected to Vest Options increased by 6.5% to $100.80 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $92.29 to $100.80.
Helps investors understand the average strike price of the company's long-term equity incentive overhang.
This is the weighted average exercise price for the total pool of vested and expected-to-vest stock options. It serves a...
Consistent with long-term compensation strategy and historical grant pricing.
weighted_avg_exercise_price_vested_expected| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $60.98 | $61.89 | $66.52 | $66.91 | $66.76 | $71.53 | $63.69 | $64.96 | $80.85 | $81.65 | $82.05 | $92.29 | $93.30 | $94.68 | $100.80 |
| QoQ Change | — | +1.5% | +7.5% | +0.6% | -0.2% | +7.1% | -11.0% | +2.0% | +24.5% | +1.0% | +0.5% | +12.5% | +1.1% | +1.5% | +6.5% |
| YoY Change | — | — | — | +9.7% | +7.9% | +7.5% | -4.8% | -2.7% | +13.0% | +28.2% | +26.3% | +14.1% | +14.3% | +15.4% | +9.2% |